Suggestions
Christopher Ghadban
Principal at Alix Ventures, Advisor, and Strategy & Innovation Professional in the Life Sciences Sector
Christopher Ghadban is an entrepreneur and venture capitalist currently serving as an investor at The Venture Collective (TVC). He is dedicated to supporting early-stage startups, particularly those focused on deep technology and innovations that leverage biology to enhance human and planetary health. His work emphasizes the importance of frontier technologies in creating a more equitable future.3
Education and Background
Ghadban is an alumnus of The Wharton School, which is known for its strong emphasis on business and finance. His educational background has equipped him with the skills necessary to navigate the complexities of venture capital and entrepreneurship.1
Professional Experience
- The Venture Collective (TVC): As an investor, Ghadban focuses on identifying and nurturing innovative startups that are at the forefront of technological advancement.
- Alix Ventures: He also holds a position as Chief of Staff at Alix Ventures, where he engages in early seed financing and investment strategies.43
Interests and Contributions
Ghadban is passionate about fostering innovation in sectors that address significant global challenges. He frequently shares insights on investment trends and the evolving landscape of biotechnology through his social media platforms.25
Overall, Christopher Ghadban's work reflects a commitment to advancing technologies that promise substantial benefits for society.
Highlights
Fantastic news for patients! Truly exciting to witness the early and, hopefully continually, broadening array of options, and eagerly anticipating the development of corresponding diagnostics for the space
BIOS Builders 🧱 w/ Maddison Masaeli - Co-Founder & CEO @ Deepcell
Tune into our exciting discussion w/ Maddison as she gives insights about Deepcell's offering of an AI-powered imaging and microfluidics platform that identifies and isolates viable cells based on morphological distinctions for use in translational research, diagnostic testing, and therapeutics. Spun out of Stanford University in 2017, the company has created unique, microfluidics-based technology that uses continuously learning AI to classify cells based on detailed visual features and sort them without inherent bias.
Maddison Masaeli is a strong believer in the power of engineering to advance the world of life sciences and to accelerate biological discovery. She invented Deepcell’s AI-based single-cell analysis and sorting technology with her postdoctoral advisor Euan Ashley and Mahyar Salek, and spun the company out of Stanford University in 2017. Originally from Tehran, Iran, she has a multidisciplinary background with experience in electrical engineering, computer science, and bioengineering. Maddison holds a bachelor’s degree in electrical engineering from Sharif University of Technology, as well as a master’s degree in computer science and a PhD in bioengineering from the University of California, Los Angeles. She has published several papers in top-tier journals and has co-invented multiple patented technologies.
See our episode below... https://buff.ly/3LIIs9d
#DeepcellInnovation #AIinMedicine #MicrofluidicsTech #BiologicalDiscovery #LifeSciencesAdvancement #TranslationalResearch #DiagnosticTesting #Therapeutics #StanfordInnovation #BiotechInnovation #STEMAdvancement #CellAnalysisTech
